Menu Search
Equities

Sigma Healthcare Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SIG:ASX

Sigma Healthcare Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (AUD)2.73
  • Today's Change-0.02 / -0.73%
  • Shares traded18.09m
  • 1 Year change-7.14%
  • Beta0.9396
Data delayed at least 20 minutes, as of Mar 03 2026 05:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sigma Healthcare Limited is an Australian retail pharmacy franchisor and a full-line pharmaceutical wholesaler and distributor. The Company, as a retail pharmacy franchisor, provides intellectual property and support services to a combined network of approximately 880 Australian Franchise Network stores operating under a suite of core franchise brands including Chemist Warehouse, My Chemist, Amcal and Discount Drug Stores. It also partly owns around 50 retail pharmacies in New Zealand, 10 retail pharmacies in Ireland and two retail pharmacies in Dubai, and 10 retail stores in China through services agreements with local companies. The Company, as a full-line wholesaler and distributor, supplies and delivers prescription products (including Pharmaceutical Benefits Scheme medicines), over the counter (OTC) and front of store (FOS) products to over 3,500 pharmacy customers. Its wholesale customers include the Retail Network as well as independent pharmacies in Australia.

  • Revenue in AUD (TTM)--
  • Net income in AUD--
  • Incorporated1999
  • Employees156.00
  • Location
    Sigma Healthcare LtdLevel 6, 2125 Dandenong Road, ClaytonMELBOURNE 3168AustraliaAUS
  • Phone+61 39215-9215
  • Fax+61 39215-9188
  • Websitehttps://sigmahealthcare.com.au/
More ▼

Institutional shareholders

7.79%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Feb 2026156.11m1.35%
Cooper Investors Pty Ltd.as of 12 Feb 2025115.45m1.00%
BlackRock Fund Advisorsas of 06 Feb 2026106.65m0.92%
Vanguard Investments Australia Ltd.as of 31 Jan 2026103.05m0.89%
Challenger Ltd. (Investment Management)as of 12 Feb 202581.43m0.71%
Perpetual Investment Management Ltd.as of 11 Nov 202481.43m0.71%
Greencape Capital Pty Ltd.as of 12 Feb 202581.43m0.71%
State Street Global Advisors, Australia, Ltd.as of 14 Feb 202563.79m0.55%
Geode Capital Management LLCas of 26 Feb 202661.24m0.53%
Norges Bank Investment Managementas of 30 Jun 202548.97m0.42%
More ▼
Data from 31 Dec 2025 - 27 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.